Epilepsy 12 combined organisational and clinical audits: Report for England and Wales Round 3 Cohort 1 (2018-19)

Reports | Published: 10 Sep 2020

Epilepsy is a condition whereby individuals are prone to recurrent epileptic seizures – abnormal movement or behaviour as a direct result of a change in the electrical activity of the brain. Epileptic seizures affect 112,000 children and young people in the UK.

This is a combined report of the organisational and clinical audits by the National Clinical Audit of Seizures and Epilepsies in Children and Young People, also known as Epilepsy12. The results detailed in the report reflect data submitted by 145 registered Health Boards and Trusts across England and Wales.

The report focuses on performance indicators relating to the first paediatric assessments undertaken for children and young people who experience a paroxysmal episode or episodes (includes all epileptic or non-epileptic seizures and also seizures of uncertain in origin) between July 2018 – December 2018 and the first year of care that follows those initial assessments up until 30 November 2019.

You can read the report by clicking on the link below. Please note you will be prompted to register your details so you can receive updates. You may skip the registration process if you prefer.

Don’t miss out. Sign up to be notified when this resource is updated and to receive updates about other related quality improvement resources, events and news from HQIP. Or you can  .


By continuing you agree to receive emails with updates and other information from HQIP and you are confirming you are over the age of 13.

Please read our privacy policy to understand how HQIP uses the information you provide, your use of HQIP’s website and your interaction with the marketing emails to improve the relevance of the communications we send you. You can unsubscribe at any time.

I have read and agree with the contents of the privacy policy.

Epilepsy 12 combined organisational and clinical audits: Report for England and Wales Round 3 Cohort 1 (2018-19)